BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15203092)

  • 41. Genomic medicines for oncology: early lessons.
    Simons JW
    J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.
    Abdel-Hamid IA; Andersson KE
    Pharmacogenomics; 2009 Oct; 10(10):1625-44. PubMed ID: 19842936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pharmacogenomics primer.
    Court MH
    J Clin Pharmacol; 2007 Sep; 47(9):1087-103. PubMed ID: 17664254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead.
    Nebert DW; Vesell ES
    Eur J Pharmacol; 2004 Oct; 500(1-3):267-80. PubMed ID: 15464039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
    Grant SF; Hakonarson H
    Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of genomics on anti-infectives drug discovery and development.
    Parkinson T
    Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparing for the revolution--pharmacogenomics and the clinical lab.
    Mehr IJ
    Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacogenomics and big genomic data: from lab to clinic and back again.
    Lavertu A; McInnes G; Daneshjou R; Whirl-Carrillo M; Klein TE; Altman RB
    Hum Mol Genet; 2018 May; 27(R1):R72-R78. PubMed ID: 29635477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic horizons--the human genome.
    Broder S; Caplan A; Evans WE
    J Am Pharm Assoc (Wash); 2002; 42(5 Suppl 1):S22-3. PubMed ID: 12296540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacogenomics - a promise in clinical practice].
    Bredeţean O; Ciochină AD
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):7-10. PubMed ID: 12089963
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacogenomics.
    Persing BF; Cheek DJ
    Nurs Clin North Am; 2000 Dec; 35(4):975-80. PubMed ID: 11072282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets.
    Amouyel P
    Pharmacogenomics; 2002 Jan; 3(1):1-3. PubMed ID: 11966396
    [No Abstract]   [Full Text] [Related]  

  • 60. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.
    Russo R; Capasso M; Paolucci P; Iolascon A;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():17-27. PubMed ID: 21069522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.